NCT07702123

Brief Summary

metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Jun 2026Sep 2026

Study Start

First participant enrolled

June 2, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2026

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 9, 2026

Last Update Submit

July 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • high density lipoprotin

    it is a lipid profile component

    it will be asessed after 12 weeks

Secondary Outcomes (14)

  • triglycrides

    It will be assessed after 12 weeks

  • body mass index

    It will be assessed after 12 weeks

  • waist circumfrence

    It will be assessed after 12 weeks

  • fasting blood glucoses

    It will be assessed after 12 weeks

  • systolic blood presssure

    It will be assessed after 12 weeks

  • +9 more secondary outcomes

Study Arms (2)

group I

EXPERIMENTAL

metabolci syndrom-fenales with behcet disorderallocated to Group I (n=20) will perform treadmill walk for 40 minutes.

Behavioral: treadmill walking

group II

NO INTERVENTION

metabolci syndrom-females with behcet disorder (n=20) allocated to Group II (n=20) will act as waitlist group.

Interventions

metabolci syndrom-females with behcet disorder assigned to group I (n=20) will perform treadmill walk for 40 minutes, thrice weekly, for 12 weeks

group I

Eligibility Criteria

Age40 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • females with metabolci syndrome
  • females with behcet disorder

You may not qualify if:

  • psychatric diseases women
  • mental diseased women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, Dokki, Egypt

RECRUITING

MeSH Terms

Conditions

Metabolic SyndromeBehcet Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesMouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesVasculitisVascular DiseasesCardiovascular DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Vascular

Study Officials

  • Ali MA Ismail, lecturer

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ali Ismail, lecturer

CONTACT

Ali mohamed, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer department of cardiovascular/repsiratory disorder and geriatrics, faculty of physical therpay cairo university

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 14, 2026

Study Start

June 2, 2026

Primary Completion (Estimated)

September 14, 2026

Study Completion (Estimated)

September 14, 2026

Last Updated

July 14, 2026

Record last verified: 2026-07

Locations